MDMEOET

MDMEOET, also known as Methylthioamphetamine or by its chemical name 3,4-methylenedioxy-N-methyl-ethylamphetamine, is a lesser-known psychedelic drug and a chemical compound belonging to the amphetamine class. It is closely related to more widely known substances such as MDMA (ecstasy) and MDEA (Eve). MDMEOET is part of the substituted amphetamines group, which are derivatives of amphetamines that have been modified to produce different effects, including psychedelic, stimulant, and empathogenic properties.

Chemistry

MDMEOET is a synthetic molecule of the phenethylamine and amphetamine chemical classes. Its structure is similar to that of MDMA, with the primary difference being the substitution of a methylthio group in place of the methylenedioxy bridge found in MDMA. This slight modification significantly alters the pharmacological properties of the compound, making its effects and potency distinct from those of its more famous relatives.

Pharmacology

The pharmacological action of MDMEOET is primarily as a serotonin, dopamine, and norepinephrine releaser or reuptake inhibitor, similar to other compounds in its class. However, the exact mechanism of action and the full profile of its interaction with various neurotransmitter systems remain less understood due to the limited research available. Its effects are believed to be a combination of stimulant, empathogenic, and psychedelic properties, although reports from users suggest that it may lean more towards the psychedelic side compared to MDMA.

Effects

Users of MDMEOET report a variety of effects, including enhanced mood, increased empathy, altered perception of time and space, visual hallucinations, and increased sensory perception. The duration of its effects can vary but generally lasts several hours. As with many psychoactive substances, the experience can be highly subjective and influenced by a multitude of factors including dose, individual physiology, and setting.

Legality

The legal status of MDMEOET varies by country, but it is often controlled under analog acts or specific drug legislation due to its structural and pharmacological similarities to other regulated substances. In many jurisdictions, its manufacture, distribution, possession, and use are restricted or illegal.

Research and Medical Use

As of now, there is limited research on MDMEOET, and it has no accepted medical use. Its potential therapeutic benefits, safety profile, and long-term effects are not well-documented, making it a substance of interest primarily in the field of psychopharmacology research.

See Also

• Psychedelic drug
• Amphetamine
• Phenethylamine
• MDMA
• MDEA

MDMEOET Resources
Latest articles Most recent articles Ongoing trials	Wikipedia